# Consistency of Response With Rimegepant in Acute Treatment of Migraine

> **NCT06898047** · — · ACTIVE_NOT_RECRUITING · sponsor: **Pfizer** · enrollment: 250 (estimated)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Rimegepant for acute migraine treatment

## Key facts

- **NCT ID:** NCT06898047
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-11-15
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06898047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06898047, "Consistency of Response With Rimegepant in Acute Treatment of Migraine". Retrieved via AI Analytics 2026-09-01 from https://api.ai-analytics.org/clinical/NCT06898047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*